戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  the expression of miRNA-485, as a PGC1alpha upstream regulator.
2      TGF-beta1 was identified as the primary upstream regulator.
3 le evidence on the potential relevance of an upstream regulator.
4 bout how expression of Eya1 is controlled by upstream regulators.
5  compared with curated data sets to identify upstream regulators.
6 et there is little information regarding its upstream regulators.
7 sponses at the level of genes, pathways, and upstream regulators.
8  and Rictor were identified as potential key upstream regulators.
9 epair pathways and altered activities of key upstream regulators.
10 n analysis of transcription factors to infer upstream regulators.
11 s a Bayesian approach to infer corresponding upstream regulators.
12 titumor activity but circumvented control by upstream regulators.
13 e ERK1/2 activation by BCAR1/BCAR3 and other upstream regulators.
14 volves loss of duplicate copies of genes and upstream regulators.
15 ps into account to arrive at the best set of upstream regulators.
16                 Transcriptional networks and upstream regulator analyses showed FOXA3, HNF4alpha, NR1
17  proinflammatory functional gene sets, while upstream regulator analysis coupled with Western blottin
18                                              Upstream regulator analysis demonstrated that extinction
19                                              Upstream regulator analysis further identified Myc as th
20                     Pathways, functional and upstream regulator analysis of the intersections between
21                                              Upstream regulator analysis predicted the TLR4 ligands,
22                                              Upstream regulator analysis showed both RV-A and, althou
23                                              Upstream regulator analysis suggests neurodegeneration-a
24                  The causal analytics tools 'Upstream Regulator Analysis', 'Mechanistic Networks', 'C
25                  The causal analytics tools 'Upstream Regulator Analysis', 'Mechanistic Networks', 'C
26 bination of differential expression testing, upstream regulator analysis, clustering techniques, and
27             By leveraging causal network and upstream regulator analysis, we identified several candi
28      In addition, in myeloid cell DM and DFU upstream regulator analysis, we observed inhibition of i
29 ng of group-level data used a combination of upstream regulator and coexpression network analysis, fo
30                      RARbeta acts as both an upstream regulator and downstream effector of miR-22, wh
31 vivo and identify Reelin as an extracellular upstream regulator and Erk1/2 as downstream effectors of
32 r-associated protein with death domain as an upstream regulator and transforming growth factor beta-a
33          These data were analyzed to predict upstream regulators and affected signaling pathways foll
34 t significant numbers of canonical pathways, upstream regulators and cellular functions.
35                            By including both upstream regulators and downstream effectors, we can sys
36 a melanogaster, we first screened for FoxO's upstream regulators and downstream effectors.
37 ttern to that of cocaine SA with overlapping upstream regulators and downstream pathways predicted.
38                  MAPKs bind to many of their upstream regulators and downstream substrates via a shor
39               However, the identities of the upstream regulators and downstream targets that mediate
40 is predicted that LPS and MPLA share similar upstream regulators and have comparable effects on canon
41 d that PO differentially regulates predicted upstream regulators and pathways, including LPS, members
42 f differentially affected cellular pathways, upstream regulators and predicted miRNA-target interacti
43  biphasic regulation is due to repression of upstream regulators and promotion of AMS protein degrada
44 ebrates, we report deep conservation of both upstream regulators and segmental activity of enhancer e
45                                 However, the upstream regulators and signaling pathways that control
46                      We report the predicted upstream regulators and signalling pathways characterizi
47 y, we used RT-qPCR, RNA sequencing, pathway, upstream regulator, and histological analyses to demonst
48 n the Hippo field has focused on identifying upstream regulators, and a complex Hippo interactome has
49 tical role in modulating levels of KLF2, its upstream regulators, and its downstream target molecules
50 nally co-regulated mRNA subsets share common upstream regulators, and sequence elements generated by
51 entification of mRNA targets of FMRP and its upstream regulators, and the use of small molecules to s
52 , this is true even when fluctuations in the upstream regulator are far below the dissociation consta
53 involved in myogenesis have been identified, upstream regulators are less well understood.
54 s several components of the network, but its upstream regulators are still poorly characterized.
55                   Thyroid- and TH-associated upstream regulators as well as thyroid-related diseases
56 e also identified top canonical pathways and upstream regulators associated with CXCL13-CXCR5 express
57 d IFN-gamma and IL-1beta as the top enriched upstream regulators associated with higher grade of immu
58 d an evolutionary shift in many of the known upstream regulators at the base of the arthropod lineage
59 nin signalling pathway, targeting up to nine upstream regulators at the same time, thus modulating th
60 ew statistical method that will infer likely upstream regulators based on observed patterns of up- an
61  reciprocally controls the activation of its upstream regulator c-Abl.
62                               Because shared upstream regulators can ensure correlated gene expressio
63 retaining the pattern of gene expression and upstream regulators characteristic of each species.
64 tors Egr1, Atf3, Jun, Fos, and Mafb, and the upstream regulators Csf1r, Tgfb1, and Tgfbr1, which are
65 s-related pathways with LPS and cytokines as upstream regulators directly associated with heat stress
66 epigenome map, and a knockout of a predicted upstream regulator disrupts normal regeneration, validat
67                       Modules of miRegulome (upstream regulators, downstream targets, miRNA regulated
68  response gene PHOTOPERIOD1 (Ppd-H1) and its upstream regulator EARLY FLOWERING3 (HvELF3).
69 - and gain-of-function studies indicate that upstream regulators, Expanded, Merlin and Kibra, play a
70 d that they do this in parallel to the known upstream regulator Fat cadherin.
71 ive RNA-binding protein RCF3 is an important upstream regulator for heat stress-responsive gene expre
72  tool called 'TRES' that predicts the likely upstream regulators for a given gene list.
73 support for shared dysregulated pathways and upstream regulators for two brain regions in human ASD b
74 s significant under expression of atrogenes, upstream regulators (FOXO1, FOXO3, NFKB1A), key componen
75 CN5L1 liver specific knockout mice and their upstream regulator, FoxO1 protein levels are decreased v
76                     Few such cancer-specific upstream regulators have been described.
77  involving the MYC locus or mutations of its upstream regulators, how c-MYC expression is induced and
78                             Novel, potential upstream regulators identified offer potential therapeut
79 okine G-CSF (r(2)=0.0683, p < 0.05), and its upstream regulator IL-17 (r(2)=0.0891, p < 0.05) both co
80 of the top diseases, functions, pathways and upstream regulators implied that a common underlying mec
81 d that can efficiently estimate p-values for upstream regulators in current biological settings.
82 on, and demonstrate differential activity of upstream regulators in different subcellular domains.
83 different components have been identified as upstream regulators in Drosophila and vertebrates.
84                                              Upstream regulators including the bZIP transcription fac
85 les indicated that several anti-inflammatory upstream regulators, including transforming growth facto
86 , NF-kappaB, complement, IL-6 signaling) and upstream regulators (INFgamma, IL-1beta, NF-kappaB, MYD8
87 ulation of the Hippo pathway and discovering upstream regulators is thus a major quest.
88 responsive to nutrient stress, including the upstream regulator KLF15, aminoacid catabolizing enzymes
89                  Inspection of the predicted upstream regulators led to previously unsuspected roles
90 RNA interference of MLC-4, as well as of its upstream regulators, LET-502 (Rho-associated coiled-coil
91 ng of a dicitrate transporter fecBCDE and an upstream regulator likely for iron uptake, whereas the o
92 he membrane lipid transporter ABCA1, and its upstream regulator Liver X receptor (LXR) in the macroph
93 hat location-specific activation by distinct upstream regulators may enable distinct functional outpu
94 ) was used to identify enriched pathways and upstream regulators.Measurements and Main Results: Respo
95 f ATC and suggest that ASH1L, along with its upstream regulator miR-200b-3p and its downstream mediat
96 ibit ABCB1 is to target its cancer-specific, upstream regulators, mitigating damage to normal tissue.
97 sion and recruitment of its newly identified upstream regulator MYC.
98                In bioinformatics analysis of upstream regulator networks, the Cxcl8 pathway exhibited
99 kines such as IL-1beta, IL-6, TNF-alpha; and upstream regulator, NF-kappaB.
100 wn of vacuolar H+-ATPase 12 (vha-12) and its upstream regulator, nuclear hormone receptor 31 (nhr-31)
101 Brat represses the translation of src64B, an upstream regulator of a conserved Rho-dependent pathway
102  cytosolic form of Gpx4 was identified as an upstream regulator of a novel form of non-apoptotic cell
103              Here we characterize ROR1 as an upstream regulator of ABCB1.
104     Our study indicates MIF is a central and upstream regulator of ADPKD pathogenesis and provides a
105 tion, we have identified a tension-sensitive upstream regulator of alpha-actinin-4 as synaptopodin.
106 ferase assays, we identified AtWRKY33 as the upstream regulator of AtCYP94B1 in Arabidopsis.
107  to inhibition of protein phosphatase 2A, an upstream regulator of ATM.
108 This study identifies PKCzeta as a novel key upstream regulator of BA-regulated SHP function, reveali
109                                        As an upstream regulator of BCAT1 expression, we identified Mu
110  results show that ROCK1 acts as a prominent upstream regulator of Beclin1-mediated autophagy and mai
111 sive cytoplasmic adapter molecule that is an upstream regulator of both IkappaB kinase (IKK) and c-Ju
112 o persistent pain in EAE and functions as an upstream regulator of CaMKIIalpha signaling.
113  by inhibiting mTOR, placing mTOR as a novel upstream regulator of caspase-2 and supporting the possi
114        Interleukin 2 (IL-2) was an important upstream regulator of CD4+ T cells from VL patients, and
115 tified cyclin-dependent kinase (CDK) 6 as an upstream regulator of CDK2 controlling SAMHD1 phosphoryl
116 ctor AP-2gamma (TFAP2C) functions as a novel upstream regulator of Cdx2 expression and position-depen
117                 Oxygen (O2) acts as a potent upstream regulator of cell function.
118 ations demonstrate that GflB is an essential upstream regulator of chemoattractant-mediated cell pola
119 nscription factor E2F3 (E2F3) as a prominent upstream regulator of cocaine-induced changes in gene ex
120  In this study, we identify TIP60 as a novel upstream regulator of DeltaNp63alpha.
121 epressor histone deacetylase 4 (HDAC4) as an upstream regulator of disease progression.
122 molog of the mammalian MAGI scaffolds, is an upstream regulator of E-Cad-based AJs during cell rearra
123 , these findings define DEPTOR as a critical upstream regulator of EC activation responses and sugges
124 Zip 1 (SPZ1) acts as a proto-oncogene and an upstream regulator of EMT during tumorigenesis.
125          Thus, we identify Aurora-B as a key upstream regulator of end-on conversion in human cells a
126 d a novel regulatory mechanism of MSI2 as an upstream regulator of ESR1 and revealed the clinical rel
127 findings reveal mitochondrial dynamics as an upstream regulator of essential mechanisms governing ste
128                     Scube3 may be a critical upstream regulator of fast fiber myogenesis by modulatin
129 threonine-specific kinase p38 as a druggable upstream regulator of FOXC2 stability and function that
130  synthase kinase-3 (GSK3) was found to be an upstream regulator of FoxM1 because GSK3 inhibition or r
131                        Hence, Fra-2 is a key upstream regulator of Foxo1 and Irf4 expression and infl
132 protein kinase, is a previously unidentified upstream regulator of Foxo1.
133 1alpha induction, suggesting that KLF5 is an upstream regulator of HIF-1alpha.
134                                    Ajuba, an upstream regulator of Hippo signaling that functions as
135                     Retinoic acid is a known upstream regulator of HOXA5 expression.
136 , we identify the ABL2 tyrosine kinase as an upstream regulator of HSF1 protein expression and show t
137 re, we identify HNF4alpha as a potential key upstream regulator of IBD candidate genes.
138 helix-loop-helix (bHLH) transcription factor Upstream Regulator of IRT1 (URI) acts as an essential pa
139 uman peripheral blood cells and to define an upstream regulator of its activation through the release
140      In the present study, we identified the upstream regulator of Jab1/Csn5 expression and demonstra
141 hese data demonstrate that DLK is a critical upstream regulator of JNK-mediated neurodegeneration dow
142 itor of DNA binding protein 2 (ID2) as a key upstream regulator of KDR activation during myeloid diff
143 A2 transcription factor was identified as an upstream regulator of miR-194, consistent with a strong
144 hioredoxin-interacting protein (TXNIP) as an upstream regulator of miR-204, we also assessed whether
145           These findings identify 5-HT as an upstream regulator of mitochondrial biogenesis and funct
146 0 (MAP4K) member, we tested whether it is an upstream regulator of MLK3.
147                      The loss of RASSF1A (an upstream regulator of MOAP-1) is one of the earliest det
148 ough Raptor-associated mTORC1 is a known key upstream regulator of mRNA translation, initiation and e
149 s analysis has identified p120-catenin as an upstream regulator of neurogenesis and cell cycle pathwa
150                                   A critical upstream regulator of NF-kappaB activation is protein ki
151 Collectively, our results uncover MLK4 as an upstream regulator of NF-kappaB signaling and a potentia
152 ticular, c-MYC was identified as a candidate upstream regulator of OGT target genes and OGT inhibitio
153 ggesting a novel role for this protein as an upstream regulator of p100.
154 ough CDC42 has previously been considered an upstream regulator of Pak2, we found a paradoxical decre
155 cers, indicative of DNA methylation being an upstream regulator of phylotypic enhancer function.
156 vious findings that cell surface GRP78 is an upstream regulator of PI3K/AKT signaling, we show here t
157 kappaB pathway, implying that Fyn is a major upstream regulator of proinflammatory signaling.
158                            Thus, Trex1 is an upstream regulator of radiation-driven anti-tumour immun
159                  Targeting CDK9 or c-MYC, an upstream regulator of RBPJ, with small molecules also de
160 identifies CHD7 as a previously unrecognized upstream regulator of Reln, and provides direct in vivo
161 sphate tensin homolog on chromosome 10 is an upstream regulator of renal PPM1A deregulation.
162 F breakpoint cluster region (Bcr) as a major upstream regulator of RhoA activity, stress fibers, and
163 variants, we provide evidence that Nck is an upstream regulator of RhoA-dependent, MMP14-mediated bre
164 aliana activating factor1 (ATAF1) as a novel upstream regulator of senescence.
165                 We present evidence that the upstream regulator of sigma(F), the phosphatase SpoIIE,
166 our data suggest that Mesp-b is an intrinsic upstream regulator of skeletal muscle progenitors and th
167 , our data indicate that OsMADS26 acts as an upstream regulator of stress-associated genes and thereb
168 e ubiquitin-modifying enzyme TNFAIP3/A20, an upstream regulator of T cell receptor (TCR) signaling in
169                             TGFbeta is a key upstream regulator of T cell reprogramming and contribut
170 primary response (MyD)88 pathway was crucial upstream regulator of TAK-1 and NF-kappaB p50/p65 activa
171           Finally, we establish ZNF143 as an upstream regulator of TARBP2 expression.
172                 We also identify Stat3 as an upstream regulator of Tcf3.
173 rved an attenuation of NF-kappaB pathway, an upstream regulator of the aforementioned genes, concomit
174 e recapitulated by mutations in Expanded, an upstream regulator of the conserved Hippo pathway, and m
175 led that Pals1 functions as a dose-dependent upstream regulator of the crosstalk between Hippo- and T
176 ed ataxia telangiectasia mutated protein, an upstream regulator of the DDR pathway, and we found a si
177 rferon gamma was identified as a significant upstream regulator of the expression changes for RR and
178          We further identify that Brd4 is an upstream regulator of the expression of c-Myc which has
179 rexpression increased expression of PAR1, an upstream regulator of the Hippo pathway; PAR1 promotes i
180             KIBRA (kidney brain protein), an upstream regulator of the Hippo signaling pathway encode
181 uction in neurofibromin 2/Merlin protein, an upstream regulator of the Hippo signaling pathway, at le
182 t the cytoskeleton-membrane interface, as an upstream regulator of the Hippo signaling pathway.
183 onclude that alpha6 integrin is an essential upstream regulator of the IGF-1R survival pathway that r
184 LEAFY-like genes in Welwitschia, could be an upstream regulator of the MADS-box genes APETALA3/PISTIL
185 testicular development, thereby acting as an upstream regulator of the male pathway in P. sinensis.
186 res a bidirectional promoter with MAP3K4, an upstream regulator of the MAPK signaling pathway, and re
187 rter of EMT, we discovered that S100A4 is an upstream regulator of the master EMT regulators SNAIL2 a
188                The CaMKK2/CaMKIV relay is an upstream regulator of the oncogenic mammalian target of
189 monstrates that alpha2M*/CS-GRP78 acts as an upstream regulator of the PDK1/PLK1 signaling axis to mo
190                     Fam20C is potentially an upstream regulator of the phosphate-regulating hormone f
191  findings support the notion that BAG2 is an upstream regulator of the PINK1/PARKIN signaling pathway
192 studies have demonstrated that cyclin D1, an upstream regulator of the Rb/E2F pathway, is an essentia
193 SCL1 and RET implicated ASCL1 as a potential upstream regulator of the RET oncogene.
194 nflammatory cytokine that acts as a critical upstream regulator of the SA secretory phenotype (SASP).
195 NB1 is an integral component and not only an upstream regulator of the spindle checkpoint pathway.
196   Thus, Pitx2 has long been considered as an upstream regulator of the transcriptional hierarchy in e
197    Another recent study predicted E2F3 as an upstream regulator of the transcriptional response to co
198 and identifies Hedgehog signaling as a novel upstream regulator of their prosensory function in the m
199 The transcription factor CREB is a predicted upstream regulator of this network and binds to the Zfp1
200 imicrobial function, was identified as a key upstream regulator of this process.
201 ranscriptional repressor ZBTB1 is a critical upstream regulator of TLS.
202            These results identify PSR1 as an upstream regulator of TORC1 and demonstrate that TORC1 i
203            Our results define Rspo1 as a key upstream regulator of two crucial pathways necessary for
204 ation factor 6 (ARF6), a small G protein and upstream regulator of type I phosphatidylinositol phosph
205               Our study identifies PKA as an upstream regulator of UBE3A activity and shows that an a
206 initiated by lysophosphatidic acid (LPA), an upstream regulator of Yap that can cause fetal haemorrha
207                                  However, no upstream regulators of ankyrin-G at synapses are known.
208 orks (TO-GCNs), which can be used to predict upstream regulators of any genes in the GCNs.
209  effectors of ATR have been established, the upstream regulators of ATR and the effect of such regula
210 binding proteins cofilin and VASP, which are upstream regulators of conformational integrin changes.
211                   A molecular screen to find upstream regulators of cVg1 in normal embryos and in emb
212 all regulatory RNAs (microRNAs) that control upstream regulators of cytoskeletal proteins are also in
213 ta signaling and a network of four miRNAs as upstream regulators of DeltaNp63, providing key informat
214  Nck-interacting kinase (TNIK or MAP4K7), as upstream regulators of DLK/JNK signaling in neurons.
215                                     However, upstream regulators of Etv2 in hemangiogenesis, generati
216 n factors NAC25 and NAC1L were identified as upstream regulators of EXPA2 expression, gibberellin-med
217                          Here, we identified upstream regulators of GhCYC3, a gene that specifies ray
218 teins in different developmental contexts as upstream regulators of Hox genes-as factors that interac
219               Very little is known about the upstream regulators of HSFs.
220                                 IL-1beta and upstream regulators of IFN-gamma, IL-12, and IL-18 were
221  known, relatively little is known about the upstream regulators of insulin transcription.
222 ) dual-specificity phosphatases as potential upstream regulators of ischemic neuronal death and Cdk4
223 ing a bioinformatics approach, we identified upstream regulators of KIM-1 after AKI.
224 vations highlight Chk1 and STAT3 as critical upstream regulators of KIM-1 expression after AKI and ma
225 AM-1 expression, and decreased expression of upstream regulators of KLF2 (ERK5 and MEF2).
226 GTPases, RhoA, Rac1, and Cdc42, as potential upstream regulators of membrane fusion.
227                                 However, the upstream regulators of miRNA biogenesis machineries rema
228                                     describe upstream regulators of mTORC1 activity which promote pal
229 mponents of the gamma-secretase complex, are upstream regulators of multiple cellular pathways via re
230 diovascular side effects because they target upstream regulators of muscle contraction.
231                               We discuss the upstream regulators of myogenesis that lead to the activ
232 l border specifiers Pax3 and Zic1 are direct upstream regulators of neural crest specifiers Snail1/2,
233 rial function directly by phosphorylation of upstream regulators of PGC-1alpha and subsequently decre
234 Frs2alpha and tyrosine phosphatase Shp2, two upstream regulators of Ras signaling.
235 ving regeneration gene expression as well as upstream regulators of regeneration are identified and v
236                            Although multiple upstream regulators of RhoA have been identified, the te
237 H), pyroglutamylated RFamide, and luqin, all upstream regulators of sexual reproduction.
238                                  To identify upstream regulators of Shank3 abundance, we performed a
239 he storage product of excess cholesterol, as upstream regulators of Tau early during AD development.
240  use of integrative analyses for identifying upstream regulators of the affected downstream molecular
241                      We identified potential upstream regulators of the core network, including inter
242                                        Other upstream regulators of the Hippo pathway mediate this ef
243 lated or its relationship to the other known upstream regulators of the Hippo pathway remains poorly
244     High-confidence ASD risk genes emerge as upstream regulators of the network, and many risk genes
245                                Prediction of upstream regulators of the OPC stroke transcriptome iden
246  Recently, oncogenic mutations in NRAS/KRAS, upstream regulators of the RAF/MEK/ERK pathway, have bee
247 eleasing Factor 1 (RasGRF1) and 2 (RasGRF2), upstream regulators of the Ras-ERK signaling cascade, on
248 g growth factor-beta, and IL-13 as potential upstream regulators of the serum protein patterns in the
249 y, to create membrane domains that partition upstream regulators of the TORC1 and TORC2 signaling pat
250     Although many mysteries remain about the upstream regulators of these changes, we review the core
251   A TGFbeta-regulated miRNA network acted as upstream regulators of this oscillatory expression of De
252 nuity Pathway Analysis demonstrated that the upstream regulators of type I and type III interferons,
253 n factor that modulates the transcription of upstream regulators of WNT and MAPK-ERK signaling to saf
254 ockout of Lats1 and Lats2 kinase, the direct upstream regulators of YAP and TAZ.
255 hat this approach can correctly identify the upstream regulator on expression data sets for which the
256 thout further significant changes to pathway/upstream regulator or network profiles.
257 oma, only a handful of lincRNAs are known as upstream regulators or downstream effectors of oncogenes
258 t this regulation occurs not at the level of upstream regulators or primary cilia, but rather at the
259                   Suppression of phc1 or its upstream regulator, p53, rescues the loss of both Notch
260 encing miR-34a expression independent of its upstream regulator, p53.
261 etal muscle, and with the suppression of the upstream regulators PGC1alpha and AMPKalpha2.
262 updosing detected minimal changes to pathway/upstream regulator profiles despite 32.5% symptom reduct
263                          We compared several upstream regulator profiles, including constant expressi
264 overed cell-type heterogeneity and predicted upstream regulator proteins that mediate cell survival,
265 ences in the expression or function of their upstream regulators, providing insights into the genetic
266  sub-networks and the connections with their upstream regulator receptors to obtain a systems view of
267 nd microtubule-associated proteins; however, upstream regulators remain controversial due to the conf
268 viously unrecognized roles for GPR10 and its upstream regulator REST in the pathogenesis of uterine f
269 abling convergent advection of MyoII and its upstream regulators Rho1 GTP, Rok and MyoII phosphatase.
270                       Phosphorylation by its upstream regulator, RIPK3, triggers MLKL's conversion fr
271  (DNMT3a) in human cancer, the nature of its upstream regulator(s) and relationship with the master c
272                                 However, the upstream regulator(s) of 53BP1 function in DNA repair re
273 f yes-associated protein 1 (YAP1) and of its upstream regulator SRC.
274       We show that, in contrast to canonical upstream regulators such as Crumbs, Kibra, Expanded, and
275   This is all the more important since it is upstream regulators such as this that need to be directl
276 s was undisturbed, depletion of G3BP1 or its upstream regulator TDP-43 disturbed normal interactions
277 ne-triggered activation of NF-kappaB and its upstream regulator TGF-beta-activated kinase-1 in murine
278 s response networks frequently have a single upstream regulator that controls many downstream genes.
279 e Bayesian network can be queried to suggest upstream regulators that can be causally linked to the a
280 genes (DEGs), over-represented pathways, and upstream regulators that contribute to kidney disease pr
281 complex with transcription factors and their upstream regulators that control Ccl5 expression.
282 n VSMCs and connects these roles to specific upstream regulators that control their expression.
283  identification of a repertoire of intrinsic upstream regulators that drive the dopaminergic stress r
284                                              Upstream regulators that orchestrate this remarkable cha
285 geting endothelin and angiotensin, which are upstream regulators that promote VSM contraction, was no
286 in the core autophagy machinery and describe upstream regulators that respond to extracellular and in
287   Early transcriptomic changes and predicted upstream regulators that were found in all three procedu
288 icrodeletions encompassing p190RhoGAP or its upstream regulator, the Abl2/Arg tyrosine kinase, have b
289                           Loss of Abl or its upstream regulator, the adaptor protein Disabled, lead t
290 ied, little is known about the role of their upstream regulators, the Rho guanine nucleotide exchange
291 ce of ANAC019, suggesting that ANAC019 is an upstream regulator these genes for drought response and
292 rrelations associated with expression of the upstream regulators TSC1, TSC2, AKT, p-AKT, PDPK1, PTEN,
293                      Then, we identified its upstream regulator UBE2T which promotes GC progression v
294  WNK1 increases the expression of the PI3KC3 upstream regulator unc-51-like kinase 1 (ULK1), its phos
295         While Notch signaling, including its upstream regulator Vegf, is known to regulate this proce
296      Our results suggest that Arp2/3 and the upstream regulator, WAVE2, are essential co-factors hija
297                            In the screen for upstream regulators we identified a LONG PALE HYPOCOTYL
298                             In addition, key upstream regulators were predicted to be commonly regula
299 dentified transcription factor USF2 as their upstream regulator, which was also increased in nonrespo
300  triiodothyronine (reverse) were inferred as upstream regulators with differences in incidence and st

 
Page Top